| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000023753 |
| Receipt No. | R000027353 |
| Scientific Title | Effects of coingestion of glucose with protein and/or fat after exercise on insulin secretion |
| Date of disclosure of the study information | 2016/08/27 |
| Last modified on | 2020/08/27 (Ver. 9) |
| Basic information | ||
| Public title | Effects of coingestion of glucose with protein and/or fat after exercise on insulin secretion | |
| Acronym | Effects of coingestion of glucose with protein and/or fat after exercise on insulin secretion | |
| Scientific Title | Effects of coingestion of glucose with protein and/or fat after exercise on insulin secretion | |
| Scientific Title:Acronym | Effects of coingestion of glucose with protein and/or fat after exercise on insulin secretion | |
| Region |
|
|
| Condition | |||
| Condition | Normal | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the effects of post-exercise ingestion of glucose in combination with milk, which contains the balanced protein and fat, on insulin secretion. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Area under the curve for insulin level after ingestion of the test solution |
| Key secondary outcomes | Blood glucose and GIP levels,
Ratings of perceived exertion |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 5 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Ergometer exercise(30min, 120-150bpm)> Blood sampling > Ingestion of a test solutionA > Blood samplings(15,30,60,120min after ingestion) > Ergometer exercise (30min, 120-150bpm) Blood sampling
All subjects will receive five treatments(test solution A-E) on five separate days over an interval of at least 6 days. |
||
| Interventions/Control_2 | Ergometer exercise(30min, 120-150bpm)> Blood sampling > Ingestion of a test solutionB > Blood samplings(15,30,60,120min after ingestion) > Ergometer exercise (30min, 120-150bpm) Blood sampling | ||
| Interventions/Control_3 | Ergometer exercise(30min, 120-150bpm)> Blood sampling > Ingestion of a test solutionC > Blood samplings(15,30,60,120min after ingestion) > Ergometer exercise (30min, 120-150bpm) Blood sampling | ||
| Interventions/Control_4 | Ergometer exercise(30min, 120-150bpm)> Blood sampling > Ingestion of a test solutionD > Blood samplings(15,30,60,120min after ingestion) > Ergometer exercise (30min, 120-150bpm) Blood sampling | ||
| Interventions/Control_5 | Ergometer exercise(30min, 120-150bpm)> Blood sampling > Ingestion of a test solutionE > Blood samplings(15,30,60,120min after ingestion) > Ergometer exercise (30min, 120-150bpm) Blood sampling | ||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy university students who have the exercise habit and have given written informed consent
|
|||
| Key exclusion criteria | Subjects
1)who have heart disease and/or respiratory disease and/or injury 2)who having take medicine 3)with food allergies 4)who having a smoking habit 5)who had a food-dependent exercise-induced anaphylaxis 6)who are judged as ineligible by the doctor for other reasons |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Takasaki University of Health and Welfare | ||||||
| Division name | Health and Welfare | ||||||
| Zip code | 3700033 | ||||||
| Address | 37-1, Nakaorui-machi, Takasaki city, Gunma, 370-0033, Japan | ||||||
| TEL | 027-352-1290 | ||||||
| kimura@takasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Takasaki University of Health and Welfare | ||||||
| Division name | Health and Welfare | ||||||
| Zip code | 3700033 | ||||||
| Address | 37-1, Nakaorui-machi, Takasaki city, Gunma, 370-0033, Japan | ||||||
| TEL | 027-352-1290 | ||||||
| Homepage URL | |||||||
| kimura@takasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Takasaki University of Health and Welfare |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mizuno Sports Promotion Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | The University of Tokyo, Graduate School of Arts and Sciences, Department of Life Science |
| Name of secondary funder(s) | Japan Table Tennis Association |
| IRB Contact (For public release) | |
| Organization | Takasaki University of Health and Welfare |
| Address | 37-1, Nakaorui-machi, Takasaki city, Gunma, 370-0033, Japan |
| Tel | 027-352-1290 |
| mune@takasaki-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027353 |